NCT06252519View on ClinicalTrials.gov

Pharmacokinetic Profile of N-Acetyl Cysteine

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 18, 2023

Primary Completion Date

December 13, 2023

Study Completion Date

May 22, 2024

Conditions
Pharmacokinetics
Interventions
DIETARY_SUPPLEMENT

NAC

1 375 mg capsule containing N-acetyl cysteine

DIETARY_SUPPLEMENT

Neuro-NAC

3 capsules containing a total of 375 mg N-Acetyl L-Cysteine Ethyl Ester

DIETARY_SUPPLEMENT

Neuro-NAC XS

3 capsules containing a total of 75 mcg Selenium, 150 mcg Molybdenum, 1800 mg Glycine, and 375 mg N-Acetyl L-Cysteine Ethyl Ester

Trial Locations (1)

38152

Center for Nutraceutical and Dietary Supplement Research, Memphis

All Listed Sponsors
collaborator

Nature Fusions

UNKNOWN

lead

University of Memphis

OTHER

NCT06252519 - Pharmacokinetic Profile of N-Acetyl Cysteine | Biotech Hunter | Biotech Hunter